Plan B Decision Takes Center Stage: FDA Commissioner Nomination On Hold
This article was originally published in The Tan Sheet
Executive Summary
Sens. Patty Murray (D-Wash.) and Hillary Clinton (D-N.Y.) followed through on their pledge to force a decision on the Plan B switch by placing a hold on Lester Crawford's nomination as FDA commissioner on June 15
You may also be interested in...
Plan B Expected To Take Center Stage During Von Eschenbach Confirmation
FDA's handling of Barr Lab's switch application for Plan B emergency contraception likely will be a focal point in the debate surrounding Senate confirmation of Andrew von Eschenbach, MD, as FDA commissioner
Crawford Nomination Clears OIG Hurdle To Face Committee Vote, Plan B Hold
The conclusion of the HHS Inspector General's investigation into allegations against FDA Commissioner nominee Lester Crawford likely will bring the agency's delay of the Plan B emergency contraceptive switch application back into the foreground
Plan B May Prevent Vote On Crawford FDA Commissioner Confirmation
Senate Health Committee Democrats will put a hold on Lester Crawford's nomination to permanent FDA Commissioner pending an agency decision on the Rx-to-OTC switch application for Barr Labs' Plan B emergency contraceptive